Rapid complete remission of metastatic melanoma after first- line treatment with nivolumab plus tumor-infiltrating lymphocytes

被引：3

作者：

Zhao, Lingdi ^{[1
,2
]}

Yang, Yonghao ^{[1
,2
]}

Li, Wei ^{[1
,2
]}

Han, Lu ^{[1
,2
]}

Lin, Hongwei ^{[1
,2
]}

Gao, Quanli ^{[1
,2
]}

机构：

[1] Zhengzhou Univ, Dept Immunotherapy, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China

[2] Henan Canc Hosp, Zhengzhou, Henan, Peoples R China

来源：

IMMUNOTHERAPY | 2018年 / 10卷 / 13期

关键词：

melanoma; metastatic; nivolumab; tumor-infiltrating lymphocytes; UNTREATED MELANOMA; IPILIMUMAB; THERAPY; CANCER;

D O I：

10.2217/imt-2018-0056

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Melanoma is the most common type of skin cancer in both men and women in the USA. The standard treatment modality for advanced melanoma is immunotherapy, either alone or in combination. As single-agent immunotherapy is usually inadequate, combined immunotherapy might be a good choice and combined treatment modalities appropriate for melanoma need to be explored. Herein, we report a case of metastatic melanoma successfully treated with combined therapy of tumor-infiltrating lymphocytes and nivolumab. Complete remission was achieved approximately 4 months after the initiation of treatment. The treatment was well tolerated and only grade 1 fatigue occurred. The patient was still on complete remission 1 year after stopping the treatment. Our result showed that this treatment modality might be an ideal option for patients with metastatic melanoma.

引用

页码：1133 / 1136

页数：4

共 14 条

[1] PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer [J].

Donia, Marco ;

Kjeldsen, Julie Westerlin ;

Andersen, Rikke ;

Westergaard, Marie Christine Wulff ;

Bianchi, Valentina ;

Legut, Mateusz ;

Attaf, Meriem ;

Szomolay, Barbara ;

Ott, Sascha ;

Dolton, Garry ;

Lyngaa, Rikke ;

Hadrup, Sine Reker ;

Sewell, Andrew K. ;

Svane, Inge Marie .

CLINICAL CANCER RESEARCH, 2017, 23 (19) :5779-5788

[2] Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma [J].

Dudley, ME ;

Wunderlich, JR ;

Yang, JC ;

Sherry, RM ;

Topalian, SL ;

Restifo, NP ;

Royal, RE ;

Kammula, U ;

White, DE ;

Mavroukakis, SA ;

Rogers, LJ ;

Gracia, GJ ;

Jones, SA ;

Mangiameli, DP ;

Pelletier, MM ;

Gea-Banacloche, J ;

Robinson, MR ;

Berman, DM ;

Filie, AC ;

Abati, A ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2346-2357

[3] Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma [J].

Dudley, ME ;

Wunderlich, J ;

Nishimura, MI ;

Yu, D ;

Yang, JC ;

Topalian, SL ;

Schwartzentruber, DJ ;

Hwu, P ;

Marincola, FM ;

Sherry, R ;

Leitman, SF ;

Rosenberg, SA .

JOURNAL OF IMMUNOTHERAPY, 2001, 24 (04) :363-373

[4] Burden of illness for metastatic melanoma in Canada, 2011-2013 [J].

Ernst, D. S. ;

Petrella, T. ;

Joshua, A. M. ;

Hamou, A. ;

Thabane, M. ;

Vantyghem, S. ;

Gwadry-Sridhar, F. .

CURRENT ONCOLOGY, 2016, 23 (06) :E563-E570

[5] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[6]

KRADIN RL, 1989, LANCET, V1, P577

[7] PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+and CD8+infiltrating lymphocytes [J].

Liu, Bin ;

Arakawa, Yoshiki ;

Yokogawa, Ryuta ;

Tokunaga, Shinya ;

Terada, Yukinori ;

Murata, Daiki ;

Matsui, Yasuzumi ;

Fujimoto, Ko-ichi ;

Fukui, Nobuyuki ;

Tanji, Masahiro ;

Mineharu, Yohei ;

Minamiguchi, Sachiko ;

Miyamoto, Susumu .

PLOS ONE, 2018, 13 (04)

[8] Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma [J].

Mullinax, John E. ;

Hall, MacLean ;

Prabhakaran, Sangeetha ;

Weber, Jeffrey ;

Khushalani, Nikhil ;

Eroglu, Zeynep ;

Brohl, Andrew S. ;

Markowitz, Joseph ;

Royster, Erica ;

Richards, Allison ;

Stark, Valerie ;

Zager, Jonathan S. ;

Kelley, Linda ;

Cox, Cheryl ;

Sondak, Vernon K. ;

Mule, James J. ;

Pilon-Thomas, Shari ;

Sarnaik, Amod A. .

FRONTIERS IN ONCOLOGY, 2018, 8

[9] Pembrolizumab versus Ipilimumab in Advanced Melanoma [J].

Robert, Caroline ;

Schachter, Jacob ;

Long, Georgina V. ;

Arance, Ana ;

Grob, Jean Jacques ;

Mortier, Laurent ;

Daud, Adil ;

Carlino, Matteo S. ;

McNeil, Catriona ;

Lotem, Michal ;

Larkin, James ;

Lorigan, Paul ;

Neyns, Bart ;

Blank, Christian U. ;

Hamid, Omid ;

Mateus, Christine ;

Shapira-Frommer, Ronnie ;

Kosh, Michele ;

Zhou, Honghong ;

Ibrahim, Nageatte ;

Ebbinghaus, Scot ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2521-2532

[10] Nivolumab in Previously Untreated Melanoma without BRAF Mutation [J].

Robert, Caroline ;

Long, Georgina V. ;

Brady, Benjamin ;

Dutriaux, Caroline ;

Maio, Michele ;

Mortier, Laurent ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

McNeil, Catriona ;

Kalinka-Warzocha, Ewa ;

Savage, Kerry J. ;

Hernberg, Micaela M. ;

Lebbe, Celeste ;

Charles, Julie ;

Mihalcioiu, Catalin ;

Chiarion-Sileni, Vanna ;

Mauch, Cornelia ;

Cognetti, Francesco ;

Arance, Ana ;

Schmidt, Henrik ;

Schadendorf, Dirk ;

Gogas, Helen ;

Lundgren-Eriksson, Lotta ;

Horak, Christine ;

Sharkey, Brian ;

Waxman, Ian M. ;

Atkinson, Victoria ;

Ascierto, Paolo A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :320-330

← 1 2 →